773 related articles for article (PubMed ID: 11061509)
21. Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.
Bellone J; Aimaretti G; Bellone S; Baffoni C; Corneli G; Origlia C; Cappa M; Ghigo E
J Endocrinol Invest; 2000 Feb; 23(2):97-101. PubMed ID: 10800762
[TBL] [Abstract][Full Text] [Related]
22. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Arvat E; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
[TBL] [Abstract][Full Text] [Related]
23. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man.
Ghigo E; Miola C; Aimaretti G; Valente F; Procopio M; Arvat E; Yin-Zhang W; Camanni F
Metabolism; 1992 Sep; 41(9):1000-3. PubMed ID: 1355580
[TBL] [Abstract][Full Text] [Related]
24. Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone.
Bondanelli M; Ambrosio MR; Margutti A; Franceschetti P; Zatelli MC; degli Uberti EC
Neuroendocrinology; 2003 Jun; 77(6):380-7. PubMed ID: 12845224
[TBL] [Abstract][Full Text] [Related]
25. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.
Gasperi M; Aimaretti G; Scarcello G; Corneli G; Cosci C; Arvat E; Martino E; Ghigo E
J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652
[TBL] [Abstract][Full Text] [Related]
26. Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers.
Broglio F; Benso A; Gottero C; Vito LD; Granata R; Arvat E; Bobbio M; Trevi G; Ghigo E
Clin Endocrinol (Oxf); 2001 Dec; 55(6):755-8. PubMed ID: 11895217
[TBL] [Abstract][Full Text] [Related]
27. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E
J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
[TBL] [Abstract][Full Text] [Related]
28. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
Biller BM; Samuels MH; Zagar A; Cook DM; Arafah BM; Bonert V; Stavrou S; Kleinberg DL; Chipman JJ; Hartman ML
J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342
[TBL] [Abstract][Full Text] [Related]
30. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO
J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
[TBL] [Abstract][Full Text] [Related]
31. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
[TBL] [Abstract][Full Text] [Related]
32. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
Broglio F; Benso A; Gottero C; Prodam F; Grottoli S; Tassone F; Maccario M; Casanueva FF; Dieguez C; Deghenghi R; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2002 Aug; 57(2):265-71. PubMed ID: 12153607
[TBL] [Abstract][Full Text] [Related]
33. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone (GH) response to GH-releasing peptide-6 in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.
Catalina PF; Mallo F; Andrade MA; García-Mayor RV; Diéguez C
J Clin Endocrinol Metab; 1998 Oct; 83(10):3663-7. PubMed ID: 9768681
[TBL] [Abstract][Full Text] [Related]
35. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
36. Effects of beta-adrenergic agonists and antagonists on the growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
Gianotti L; Arvat E; Valetto MR; Ramunni J; Di Vito L; Maccagno B; Camanni F; Ghigo E
Biol Psychiatry; 1998 Feb; 43(3):181-7. PubMed ID: 9494699
[TBL] [Abstract][Full Text] [Related]
37. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
38. Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients.
Grottoli S; Razzore P; Arvat E; Oleandri SE; Rossetto R; Ciccarelli E; Camanni F; Ghigo E
J Endocrinol Invest; 1997 Nov; 20(10):597-602. PubMed ID: 9438917
[TBL] [Abstract][Full Text] [Related]
39. Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood.
Bellone J; Aimaretti G; Valetto MR; Bellone S; Baffoni C; Arvat E; Seminara S; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Oct; 135(4):421-4. PubMed ID: 8921823
[TBL] [Abstract][Full Text] [Related]
40. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome.
Leal-Cerro A; Povedano J; Astorga R; Gonzalez M; Silva H; Garcia-Pesquera F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3378-81. PubMed ID: 10487713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
